$CYCN Cyclerion Therapeutics, Inc. Insider Trading Week 13/2019
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Cyclerion Therapeutics, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Cyclerion Therapeutics, Inc. in week 13/2019.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Apr 03 2019 | CYCN | Cyclerion Therapeu ... | MCGUIRE TERRANCE | Director | Grant | A | 0.00 | 6,911 | 0 | 6,911 | 0 to 6.9 K |
Apr 03 2019 | CYCN | Cyclerion Therapeu ... | MCGUIRE TERRANCE | Director | Grant | A | 0.00 | 162 | 0 | 162 | 0 to 162 |
Apr 03 2019 | CYCN | Cyclerion Therapeu ... | MCGUIRE TERRANCE | Director | Grant | A | 0.00 | 3,279 | 0 | 3,279 | 0 to 3.3 K |
Apr 03 2019 | CYCN | Cyclerion Therapeu ... | MCGUIRE TERRANCE | Director | Grant | A | 0.00 | 7,768 | 0 | 7,768 | 0 to 7.8 K |
Apr 03 2019 | CYCN | Cyclerion Therapeu ... | Hecht Peter M | Chief Executive Off ... | Option Exercise | A | 14.20 | 857,977 | 12,183,273 | 857,977 | |
Apr 03 2019 | CYCN | Cyclerion Therapeu ... | Hecht Peter M | Chief Executive Off ... | Option Exercise | A | 16.02 | 380,393 | 6,093,896 | 380,393 | |
Apr 03 2019 | CYCN | Cyclerion Therapeu ... | Hecht Peter M | Chief Executive Off ... | Option Exercise | A | 18.46 | 344,829 | 6,365,543 | 344,829 | |
Apr 03 2019 | CYCN | Cyclerion Therapeu ... | Hecht Peter M | Chief Executive Off ... | Option Exercise | A | 11.28 | 223,919 | 2,525,806 | 223,919 | |
Apr 03 2019 | CYCN | Cyclerion Therapeu ... | Hecht Peter M | Chief Executive Off ... | Option Exercise | A | 17.20 | 56,500 | 971,800 | 56,500 | |
Apr 03 2019 | CYCN | Cyclerion Therapeu ... | Hecht Peter M | Chief Executive Off ... | Option Exercise | A | 15.54 | 37,973 | 590,100 | 37,973 | |
Apr 03 2019 | CYCN | Cyclerion Therapeu ... | Hecht Peter M | Chief Executive Off ... | Option Exercise | A | 14.40 | 43,680 | 628,992 | 43,680 | |
Apr 03 2019 | CYCN | Cyclerion Therapeu ... | Hecht Peter M | Chief Executive Off ... | Option Exercise | A | 16.21 | 36,089 | 585,003 | 36,089 | |
Apr 03 2019 | CYCN | Cyclerion Therapeu ... | Hecht Peter M | Chief Executive Off ... | Option Exercise | A | 12.23 | 53,090 | 649,291 | 53,090 | |
Apr 03 2019 | CYCN | Cyclerion Therapeu ... | Hecht Peter M | Chief Executive Off ... | Option Exercise | A | 12.39 | 12,499 | 154,863 | 12,499 | |
Apr 03 2019 | CYCN | Cyclerion Therapeu ... | Hecht Peter M | Chief Executive Off ... | Option Exercise | A | 6.04 | 2,000 | 12,080 | 2,000 | |
Apr 03 2019 | CYCN | Cyclerion Therapeu ... | Hecht Peter M | Chief Executive Off ... | Grant | A | 0.00 | 485 | 0 | 485 | 0 to 485 |
Apr 03 2019 | CYCN | Cyclerion Therapeu ... | Hecht Peter M | Chief Executive Off ... | Grant | A | 0.00 | 485 | 0 | 485 | 0 to 485 |
Apr 03 2019 | CYCN | Cyclerion Therapeu ... | Hecht Peter M | Chief Executive Off ... | Grant | A | 0.00 | 485 | 0 | 485 | 0 to 485 |
Apr 03 2019 | CYCN | Cyclerion Therapeu ... | Hecht Peter M | Chief Executive Off ... | Grant | A | 0.00 | 223,192 | 0 | 223,192 | 0 to 223.2 K |
Apr 03 2019 | CYCN | Cyclerion Therapeu ... | Currie Mark G | President | Option Exercise | A | 14.20 | 514,786 | 7,309,961 | 514,786 | |
Apr 03 2019 | CYCN | Cyclerion Therapeu ... | Currie Mark G | President | Option Exercise | A | 16.02 | 141,007 | 2,258,932 | 141,007 | |
Apr 03 2019 | CYCN | Cyclerion Therapeu ... | Currie Mark G | President | Option Exercise | A | 18.46 | 113,430 | 2,093,918 | 113,430 | |
Apr 03 2019 | CYCN | Cyclerion Therapeu ... | Currie Mark G | President | Option Exercise | A | 11.28 | 50,801 | 573,035 | 50,801 | |
Apr 03 2019 | CYCN | Cyclerion Therapeu ... | Currie Mark G | President | Option Exercise | A | 17.20 | 2,500 | 43,000 | 2,500 | |
Apr 03 2019 | CYCN | Cyclerion Therapeu ... | Currie Mark G | President | Option Exercise | A | 17.20 | 13,125 | 225,750 | 13,125 | |
Apr 03 2019 | CYCN | Cyclerion Therapeu ... | Currie Mark G | President | Option Exercise | A | 15.54 | 9,930 | 154,312 | 9,930 | |
Apr 03 2019 | CYCN | Cyclerion Therapeu ... | Currie Mark G | President | Option Exercise | A | 14.40 | 27,773 | 399,931 | 27,773 | |
Apr 03 2019 | CYCN | Cyclerion Therapeu ... | Currie Mark G | President | Option Exercise | A | 16.21 | 17,491 | 283,529 | 17,491 | |
Apr 03 2019 | CYCN | Cyclerion Therapeu ... | Currie Mark G | President | Option Exercise | A | 12.23 | 37,286 | 456,008 | 37,286 | |
Apr 03 2019 | CYCN | Cyclerion Therapeu ... | Currie Mark G | President | Option Exercise | A | 12.39 | 888 | 11,002 | 888 | |
Apr 03 2019 | CYCN | Cyclerion Therapeu ... | Currie Mark G | President | Buy | P | 14.81 | 270,107 | 4,000,285 | 321,755 | 51.6 K to 321.8 K (+522.98 %) |
Apr 03 2019 | CYCN | Cyclerion Therapeu ... | Currie Mark G | President | Grant | A | 0.00 | 51,648 | 0 | 51,648 | 0 to 51.6 K |
Apr 03 2019 | CYCN | Cyclerion Therapeu ... | Huyett William | Chief Financial Off ... | Option Exercise | A | 14.20 | 222,002 | 3,152,428 | 222,002 | |
Apr 03 2019 | CYCN | Cyclerion Therapeu ... | Huyett William | Chief Financial Off ... | Option Exercise | A | 16.81 | 221,349 | 3,720,877 | 221,349 | |
Apr 03 2019 | CYCN | Cyclerion Therapeu ... | Huyett William | Chief Financial Off ... | Grant | A | 0.00 | 39,179 | 0 | 78,912 | 39.7 K to 78.9 K (+98.61 %) |
Apr 03 2019 | CYCN | Cyclerion Therapeu ... | Huyett William | Chief Financial Off ... | Grant | A | 0.00 | 38,327 | 0 | 38,327 | 0 to 38.3 K |
Apr 03 2019 | CYCN | Cyclerion Therapeu ... | SCHULMAN AMY W | Director | Grant | A | 0.00 | 3,279 | 0 | 7,508 | 4.2 K to 7.5 K (+77.54 %) |
Apr 03 2019 | CYCN | Cyclerion Therapeu ... | SCHULMAN AMY W | Director | Grant | A | 0.00 | 4,229 | 0 | 4,229 | 0 to 4.2 K |
Apr 03 2019 | CYCN | Cyclerion Therapeu ... | Fanucci Marsha | Director | Grant | A | 0.00 | 3,279 | 0 | 16,950 | 13.7 K to 17 K (+23.99 %) |
Apr 03 2019 | CYCN | Cyclerion Therapeu ... | Fanucci Marsha | Director | Grant | A | 0.00 | 13,671 | 0 | 13,671 | 0 to 13.7 K |
Apr 03 2019 | CYCN | Cyclerion Therapeu ... | Mendelsohn Michael | Director | Grant | A | 0.00 | 2,421 | 0 | 2,421 | 0 to 2.4 K |
Apr 03 2019 | CYCN | Cyclerion Therapeu ... | Lovell Stephanie | Director | Grant | A | 0.00 | 2,421 | 0 | 2,421 | 0 to 2.4 K |
Apr 03 2019 | CYCN | Cyclerion Therapeu ... | Isacson Ole | Director | Grant | A | 0.00 | 2,421 | 0 | 2,421 | 0 to 2.4 K |
Apr 03 2019 | CYCN | Cyclerion Therapeu ... | CONRADES GEORGE H | Director | Grant | A | 0.00 | 2,421 | 0 | 2,421 | 0 to 2.4 K |
Apr 03 2019 | CYCN | Cyclerion Therapeu ... | Churchwell Kevin | Director | Grant | A | 0.00 | 2,421 | 0 | 2,421 | 0 to 2.4 K |
Apr 02 2019 | CYCN | Cyclerion Therapeu ... | IRONWOOD PHARMACEUTICALS INC | 10% Owner | Sell | J | 0.00 | 15,562,555 | 0 | 0 | 15.6 M to 0 (-100.00 %) |
Apr 02 2019 | CYCN | Cyclerion Therapeu ... | IRONWOOD PHARMACEUTICALS INC | 10% Owner | Grant | A | 0.00 | 15,562,455 | 0 | 15,562,555 | 100 to 15.6 M (+15,562,455.00 %) |